Submission for OMB Review; Screening Tool for Unaccompanied Children Program Staff and Visitors, 57434-57435 [2021-22477]
Download as PDF
<![CDATA[
57434
Federal Register / Vol. 86, No. 197 / Friday, October 15, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB #0970–0198]
Proposed Information Collection
Activity; Child Care and Development
Fund Plan for Tribes for FY 2023–2025
(ACF–118A)
Office of Child Care;
Administration for Children and
Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the
form ACF–118A: Child Care and
Development Fund for Tribes (OMB
#0970–0198, expiration 06/30/2022) for
FFY 2023–2025. There are changes
requested to the form to improve
formatting, and clarify and streamline
SUMMARY:
questions. ACF is also requesting public
comment on revising the thresholds
used to determine tribes with small,
medium, and large allocations.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: The Child Care and
Development Fund (CCDF) Plan (the
Plan) for Tribes is required from each
CCDF Lead Agency in accordance with
section 658E of the Child Care and
Development Block Grant Act of 1990
(CCDBG Act), as amended, CCDBG Act
of 2014 (Pub. L. 113–186), and 42 U.S.C.
9858. The Plan, submitted on the ACF–
118A, is required triennially, and
remains in effect for 3 years. The Plan
provides ACF and the public with a
description of and assurance about the
tribes’ child care programs. These Plans
are the applications for CCDF funds.
ACF is also seeking public comment
on whether and how to adjust the
thresholds used to determine allocation
sizes for Tribal Lead Agencies. We
differentiate and exempt some Tribal
Lead Agencies from a progressive series
of CCDF provisions based on three
categories of CCDF grant allocations—
large, medium, and small. However, the
current thresholds were set based on
FFY 2016 allocations. Since then, the
amount annually appropriated to Tribal
Lead Agencies has increased more than
threefold and ACF is considering
adjusting the thresholds accordingly.
Respondents: Tribal CCDF lead
agencies.
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
Total number of
responses per
respondent
260
106
1
1
ACF–118A Part I (for all tribes) .........................................
ACF–118A Part II (for medium and large tribes only) .......
Estimated Total Annual Burden
Hours: 11,248.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Pub. L. 113–186 and 42
U.S.C. 9858c.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021–22456 Filed 10–14–21; 8:45 am]
BILLING CODE 4184–43–P
VerDate Sep<11>2014
16:50 Oct 14, 2021
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[0970–0543]
Submission for OMB Review;
Screening Tool for Unaccompanied
Children Program Staff and Visitors
Office of Refugee Resettlement;
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Request for public comment.
AGENCY:
The Office of Refugee
Resettlement (ORR), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to continue
use of a coronavirus (COVID–19)
screening tool for unaccompanied
children (UC) program staff and visitors
at ORR care provider facilities.
DATES: Comments due within 30 days of
publication. The Office of Management
and Budget (OMB) must make a
decision about the collection of
information between 30 and 60 days
after publication of this document in the
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Average
burden hours
per response
120
24
Total burden
hours
31,200
2,544
Annual burden
hours
10,400
848
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. All emailed requests
should be identified by the title of the
information collection.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION:
Description: The COVID–19 Verbal
Screening and Temperature Check tool
is verbally administered to all staff and
visitors before they are granted access
an ORR care provider facility. The tool
asks whether the individual displays
COVID–19 symptoms, has had close
contact with individuals known to test
positive for COVID–19, has been tested
for COVID–19, has been exposed to
someone known or suspected to be
infected with COVID–19, or has been
tested for COVID–19. The tool also
requests a temperature check. The
information collected by administering
E:\FR\FM\15OCN1.SGM
15OCN1
Federal Register / Vol. 86, No. 197 / Friday, October 15, 2021 / Notices
this screening tool will help ensure the
health and safety of children and staff
at care provider facilities by helping to
identify and reduce potential exposure
to COVID–19.
57435
Respondents: Staff and visitors at
ORR care provider facilities.
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of
respondents
Annual
responses per
respondent
Average
burden hours
per response
Annual
burden hours
COVID–19 Verbal Screening and Temperature Check ..................................
15,000
260
.033
128,700
Authority: 6 U.S.C. 279.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021–22477 Filed 10–14–21; 8:45 am]
BILLING CODE 4184–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–1004]
Enhanced Drug Distribution Security at
the Package Level Under the Drug
Supply Chain Security Act; Public
Meeting; Request for Comments
Food and Drug Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting;
request for comments.
AGENCY:
The Food and Drug
Administration (FDA or the Agency) is
announcing a virtual public meeting
entitled ‘‘Enhanced Drug Distribution
Security at the Package Level Under the
Drug Supply Chain Security Act
(DSCSA).’’ This public meeting is
intended to provide members of the
pharmaceutical distribution supply
chain and other interested stakeholders
an opportunity to discuss enhanced
drug distribution security requirements
of the DSCSA related to system
attributes necessary to enable secure
tracing of product at the package level.
DATES: The public meeting will be held
on November 16, 2021, from 9 a.m. to
4 p.m., and will take place virtually.
Submit either electronic or written
comments on this public meeting by
January 18, 2022.
ADDRESSES: The public meeting will be
held virtually and hosted by FDA.
Registration to participate in this
meeting and other information can be
found at https://www.fda.gov/drugs/
news-events-human-drugs/publicmeeting-enhanced-drug-distributionsecurity-package-level-under-drugsupply-chain-security. See the
SUPPLEMENTARY INFORMATION section for
registration date and other information.
SUMMARY:
VerDate Sep<11>2014
16:50 Oct 14, 2021
Jkt 256001
Comments: To permit the widest
possible opportunity to obtain public
comment, FDA is soliciting either
electronic or written comments on all
aspects of the public meeting topics.
You may submit comments as follows.
Please note that late, untimely filed
comments will not be considered.
Please note that the deadline for
submitting either electronic or written
comments is 60 days after the meeting,
January 18, 2022, to which the
comments relate. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are postmarked or the
delivery service acceptance receipt is on
or before that date. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
the specified date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2021–N–1004 for ‘‘Enhanced Drug
Distribution Security at the Package
Level Under the Drug Supply Chain
Security Act; Public Meeting; Request
for Comments.’’ Received comments,
those filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 86, Number 197 (Friday, October 15, 2021)]
[Notices]
[Pages 57434-57435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[0970-0543]
Submission for OMB Review; Screening Tool for Unaccompanied
Children Program Staff and Visitors
AGENCY: Office of Refugee Resettlement; Administration for Children and
Families, Department of Health and Human Services.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Office of Refugee Resettlement (ORR), Administration for
Children and Families (ACF), U.S. Department of Health and Human
Services (HHS), is proposing to continue use of a coronavirus (COVID-
19) screening tool for unaccompanied children (UC) program staff and
visitors at ORR care provider facilities.
DATES: Comments due within 30 days of publication. The Office of
Management and Budget (OMB) must make a decision about the collection
of information between 30 and 60 days after publication of this
document in the Federal Register. Therefore, a comment is best assured
of having its full effect if OMB receives it within 30 days of
publication. All emailed requests should be identified by the title of
the information collection.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
SUPPLEMENTARY INFORMATION:
Description: The COVID-19 Verbal Screening and Temperature Check
tool is verbally administered to all staff and visitors before they are
granted access an ORR care provider facility. The tool asks whether the
individual displays COVID-19 symptoms, has had close contact with
individuals known to test positive for COVID-19, has been tested for
COVID-19, has been exposed to someone known or suspected to be infected
with COVID-19, or has been tested for COVID-19. The tool also requests
a temperature check. The information collected by administering
[[Page 57435]]
this screening tool will help ensure the health and safety of children
and staff at care provider facilities by helping to identify and reduce
potential exposure to COVID-19.
Respondents: Staff and visitors at ORR care provider facilities.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual Average burden
Instrument Total number of responses per hours per Annual burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
COVID-19 Verbal Screening and Temperature 15,000 260 .033 128,700
Check......................................
----------------------------------------------------------------------------------------------------------------
Authority: 6 U.S.C. 279.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021-22477 Filed 10-14-21; 8:45 am]
BILLING CODE 4184-45-P
